Promising biotech Vaxxas on Monday announced it will begin manufacturing its needle free vaccination patches in Brisbane for clinical trials after securing approval from Australian regulators. The commercialisation milestone...
Australia’s regulator of drugs and medical devices is planning to use artificial intelligence to speed up testing of new medicines already signed off in similar nations, as it comes...
A Victorian manufacturing facility meant to already be churning out a million Covid-19 rapid antigen tests per month is yet to get off the ground as Australian companies continue...
The federal government has spent a further $30 million buying imported rapid antigen tests for the aged care sector, as several Australian companies continue to wait to get local...